ClinicalTrials.govpublic full text
Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers
metastatic bladder urothelial carcinoma, metastatic renal pelvis and ureter urothelial carcinoma, refractory bladder urothelial carcinoma, refractory renal pelvis and ureter urothelial carcinoma, stage iv bladder cancer ajcc v7, stage iv renal pelvis and ureter cancer ajcc v7
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 414489
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.